Novavax's GAAP net income for the 3 months of 2022 was $203.408 million, compared to a loss of $222.719 million in the previous year. Revenue increased 57.4% to $703.971 million from $447.229 million a year earlier.
Novavax's GAAP net income for the 3 months of 2022 was $203.408 million, compared to a loss of $222.719 million in the previous year. Revenue increased 57.4% to $703.971 million from $447.229 million a year earlier. 
ir.novavax.com
English (US) 